Lung Non Small Cell Carcinoma Clinical Trials

ReadTheTrial indexes 9 studies for Lung Non Small Cell Carcinoma. The most common development stage is Phase 3 (5 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

9 clinical trials found for Lung Non Small Cell Carcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 5
56%
Phase 2 3
33%
N/A 1
11%

Trial Status Breakdown

Trials for Lung Non Small Cell Carcinoma

Evaluating Adjuvant Atezolizumab or Atezolizumab and Hyaluronidase-TQJS to Prevent Recurrence in Stage I Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase III Trial (AASI-NSCLC)

NCT07388524 · NOT YET RECRUITING · Phase 3

Qualitative Study on Detection and Treatment of Non-Small Cell Lung Cancer in Patients With a History of Alcohol or Substance Use Disorder

NCT07186699 · RECRUITING · N/A

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cancer Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)

NCT06732401 · ACTIVE NOT RECRUITING · Phase 3

Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants With Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in The AdjuvanT Setting (INSIGHT)

NCT06498635 · RECRUITING · Phase 3

A Phase II Randomized Study of Safety and Efficacy of a Multiple Antigen Vaccine (STEMVAC) in Non-Small-Cell Lung Cancer Patients

NCT05242965 · ACTIVE NOT RECRUITING · Phase 2

A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients With Borderline Performance Status

NCT04310020 · ACTIVE NOT RECRUITING · Phase 2

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC

NCT04214262 · ACTIVE NOT RECRUITING · Phase 3

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)

NCT04267848 · RECRUITING · Phase 3

Randomized Phase II Trial of Osimertinib With or Without Local Consolidation Therapy (LCT) for Patients With EGFR-Mutant Metastatic NSCLC (NORTHSTAR)

NCT03410043 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Lung Non Small Cell Carcinoma?

There are 9 clinical trials listed for Lung Non Small Cell Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Lung Non Small Cell Carcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Lung Non Small Cell Carcinoma trials in?

Current Lung Non Small Cell Carcinoma trials are distributed across: Phase 3 (5), Phase 2 (3), N/A (1).

Find More Trials